Mitochondrial defect in Huntington's disease caudate nucleus
- 1 March 1996
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 39 (3) , 385-389
- https://doi.org/10.1002/ana.410390317
Abstract
Although the Huntington's disease (HD) gene defect has been identified, the structure and function of the abnormal gene product and the pathogenetic mechanisms involved in producing death of selective neuronal populations are not understood. Indirect evidence from several sources indicates that a defect of energy metabolism and consequent excitotoxicity are involved in HD. Toxin models of HD may be induced by 3‐nitropropionic acid or malonate, both inhibitors of succinate dehydrogenase, complex II of the mitochondrial respiratory chain. We analyzed mitochondrial respiratory chain function in the caudate nucleus (n = 10) and platelets (n = 11) from patients with HD. In the caudate nucleus, severe defects of complexes II and III (53–59%, p < 0.0005) and a 32–38% (p < 0.01) deficiency of complex IV activity were demonstrated. No deficiencies were found in platelet mitochondrial function. The mitochondrial defect identified in HD caudate parallels that induced by HD neurotoxin models and further supports the role of abnormal energy metabolism in HD. The relationship of the mitochondrial defect to the role of huntingtin is not known.Keywords
This publication has 17 references indexed in Scilit:
- Genetics and molecular biology of Huntington's diseaseTrends in Neurosciences, 1995
- Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopyNeurology, 1993
- Smoking and mitochondrial function: a model for environmental toxinsQJM: An International Journal of Medicine, 1993
- Striatal glucose consumption in chorea-free subjects at risk of Huntington's diseaseZeitschrift für Neurologie, 1993
- Platelet mitochondria function in Parkinson's diseaseAnnals of Neurology, 1992
- Cortical glucose metabolism in Huntington's diseaseNeurology, 1992
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Mitochondrial function and parental sex effect in Huntington's diseaseThe Lancet, 1990
- Evidence for a defect in NADHNeurology, 1990
- Regional Mitochondrial Respiratory Activity in Huntington's Disease BrainJournal of Neurochemistry, 1985